Prediction of early clinical severity and extent of neuronal damage in anterior-circulation infarction using the initial serum neuron-specific enolase level

Archives of Neurology

Volumn 60, Issue 1, 2003, Pages 37-41

  Oh, Seung Hun ^a   Lee, Jin Goo ^a   Na, Sang Jun ^a   Park, Ji Hyung ^a   Choi, Young Chul ^a   Kim, Won Joo ^a  

^a Yonsei University College of Medicine   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

BIOCHEMICAL MARKER; NEURON SPECIFIC ENOLASE;

ACCURACY; ADULT; AGED; ARTICLE; BLOOD SAMPLING; BRAIN INFARCTION; CONTROLLED STUDY; DISEASE SEVERITY; ENZYME BLOOD LEVEL; FEMALE; FUNCTIONAL ASSESSMENT; HUMAN; MAJOR CLINICAL STUDY; MALE; NERVE CELL LESION; NUCLEAR MAGNETIC RESONANCE IMAGING; OUTCOMES RESEARCH; PREDICTION; PRIORITY JOURNAL; PROGNOSIS; RELIABILITY; SCORING SYSTEM; STROKE; VOLUMETRY;

EID: 0037227327     PISSN: 00039942     EISSN: None     Source Type: Journal    
DOI: 10.1001/archneur.60.1.37     Document Type: Article

References (35)

1. Lee BI, Nam HS, Heo JH, Kim DI. Yonsei Stroke Registry: analysis of 1,000 patients with acute cerebral infarctions. Cerebrovasc Dis. 2001;12:145-151.
2. Saunders DE, Clifton AG, Brown MM. Measurement of infarct size using MRI predicts prognosis in middle cerebral artery infarction. Stroke. 1995;26:2272-2276.
3. Pereira AC, Saunders DE, Doyle VL, et al. Measurement of initial N-acetyl aspartate concentration by magnetic resonance spectroscopy and initial infarct volume by MRI predicts outcome in patients with middle cerebral artery territory infarction. Stroke. 1999;30:1577-1582.
4. Marangos PJ, Shmechel DE. Neuron specific enolase, a clinically useful marker for neurons and neuroendocrine cells [review]. Annu Rev Neurosci. 1987;10:269-295.
5. Cunningham RT, Watt M, Winder J, et al. Serum neurone-specific enolase as an indicator of stroke volume. Eur J Clin Invest. 1996;26:298-303.
6. Cunningham RT, Young IS, Winder J, et al. Serum neurone-specific enolase (NSE) levels as an indicator of neuronal damage in patients with cerebral infarction. Eur J Clin Invest. 1991;21:497-500.
7. Barone FC, Clark RK, Price WJ, et al. Neuron-specific enolase increases in cerebral and systemic circulation following focal ischemia. Brain Res. 1993;623:77-82.
8. Hatfield RH, McKernan RM. CSF neuron-specific enolase as a quantitative marker of neuronal damage in a rat stroke model. Brain Res. 1992;577:249-252.
9. Hermann M, Curio N, Jost S, Wunderlich MT, Synowitz H, Wallesch CW. Protein S-100B and neuron-specific enolase as early neurobiochemical markers of the severity of traumatic brain injury. Restor Neurol Neurosci. 1999;14:109-114.
10. Roine RO, Somer H, Kaste M, Viinikka L, Karonen SL. Neurological outcome after out-of-hospital cardiac arrest: prediction by cerebrospinal fluid enzyme analysis. Arch Neurol. 1989;46:753-756.
11. Correale JD, Rabinowicz AL, Heck CN, Smith TD, Loskota WJ, DeGiorgio CM. Status epilepticus increases CSF levels of neuron-specific enolase and alters the blood-brain barrier. Neurology. 1998;50:1388-1391.
12. Tatu L, Moulin T, Bogousslavsky J, Duvernoy H. Arterial territories of the human brain: cerebral hemispheres. Neurology. 1998;50:1699-1708.
13. Brott T, Adams HP Jr, Olinger CP, et al. Measurements of acute cerebral infarction: a clinical examination scale. Stroke. 1989;20:864-870.
14. Bamford J, Sandercock P, Dennis M, Burn J, Warlow C. Classification and natural history of clinically identifiable subtypes of cerebral infarction. Lancet. 1991;337:1521-1526.
15. Adams HP Jr, Bendixen BH, Kappelle LJ, et al, for the TOAST (Trial of Org 10172 in Acute Stroke Treatment). Classification of subtype of acute ischemic stroke: definitions for use in a multicenter clinical trial. Stroke. 1993;24:35-41.
16. Marangos PJ, Schmechel D, Parma AM, Clark RL, Goodwin FK. Measurement of neuron-specific enolase (NSE) and non-neuronal (NNE) isoenzymes of enolase in rat, monkey and human nervous tissue. J Neurochem. 1979;33:319-329.
17. Kato K, Suzuki F, Umeda Y. Highly sensitive immunoassays for three forms of rat brain enolase. J Neurochem. 1981;36:793-797.
18. Butterworth RJ, Wassif WS, Sherwood RA, et al. Serum neuron-specific enolase, carnosinase, and their ratio in acute stroke: an enzymatic test for predicting outcome? Stroke. 1996;27:2064-2068.
19. Fassbender K, Schmidt R, Schreiner A, et al. Leakage of brain-originated proteins in peripheral blood: temporal profile and diagnostic value in early ischemic stroke. J Neurol Sci. 1997;148:101-105.
20. Kawasaki H, Wakayama Y, Okayasu H, Takahashi H, Shibuya S. Levels of serum and cerebrospinal fluid enolase in patients with cerebral vascular disease and other neurological disease. Jpn J Stroke. 1988;19:313-318.
21. Missler U, Wiesmann M, Friedrich C, Kaps M. S-100 protein and neuron-specific enolase concentrations in blood as indicators of infarction volume and prognosis in acute ischemic stroke. Stroke. 1997;28:1956-1960.
22. Persson L, Hårdemark HG, Gustafsson J, et al. S-100 protein and neuron-specific enolase in cerebrospinal fluid and serum: markers of cell damage in human central nervous system. Stroke. 1987;18:911-918.
23. Schaarschmidt H, Prange HW, Reiber H. Neuron-specific enolase concentrations in blood as a prognostic parameter in cerebrovascular disease. Stroke. 1994;25:558-565.
24. Stevens H, Jakobs C, de Jager AE, Cunningham RT, Korf J. Neurone-specific enolase and N-acetyl-aspartate as potential peripheral markers of ischaemic stroke. Eur J Clin Invest. 1999;29:6-11.
25. Wunderlich MT, Ebert AD, Kratz T, Goertler M, Jost S, Herrmann M. Early neurobehavioral outcome after stroke is related to release of neurobiochemical markers of brain damage. Stroke. 1999;30:1190-1195.
26. Sulter G, Elting JW, De Keyser J. Increased serum neuron specific enolase concentrations in patients with hyperglycemic cortical ischemic stroke. Neurosci Lett. 1998;253:71-73.
27. Hill MD, Jackowski G, Bayer N, Lawrence M, Jaeschke R. Biochemical markers in acute ischemic stroke. CMAJ. 2000;162:1139-1140
28. Zerr I, Bodemer M, Racker S, et al. Cerebrospinal fluid concentration of neuron-specific enolase in diagnosis of Creutzfeldt-Jakob disease. Lancet. 1995;345:1609-1610.
29. Saver JL, Johnston KC, Homer D, et al, for the RANTTAS Investigators. Infarct volume as a surrogate or auxiliary outcome measure in ischemic stroke clinical trials. Stroke. 1999;30:293-298.
30. Olsen TS. Outcome following occlusion of the middle cerebral artery. Acta Neurol Scand. 1991;83:254-258.
31. Lovblad KO, Baird AE, Schlaug G, et al. Ischemic lesion volumes in acute stroke by diffusion-weighted magnetic resonance imaging correlate with clinical outcome. Ann Neurol. 1997;42:164-170.
32. Warach S, Dashe JF, Edelman RR. Clinical outcome in ischemic stroke predicted by early diffusion-weighted and perfusion magnetic resonance imaging: a preliminary analysis. J Cereb Blood Flow Metab. 1996;16:53-59.
33. Thijs VN, Lansberg MG, Beaulieu C, Marks MP, Moseley ME, Albers GW. Is early ischemic lesion volume on diffusion-weighted imaging an independent predictor of stroke outcome? a multivariable analysis. Stroke. 2000;31:2597-2602.
34. Tong DC, Yenari MA, Albers GW, O'Brien M, Marks MP, Moseley ME. Correlation of perfusion- and diffusion-weighted MRI with NIHSS score in acute (<6.5 hour) ischemic stroke. Neurology. 1998;50:864-870.
35. Baird AE, Warach S. Magnetic resonance imaging of acute stroke [review]. J Cereb Blood Flow Metab. 1998;18:583-609.